{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/03/3337407/16626/en/Zevra-Therapeutics-Announces-Publication-of-Four-Year-Real-World-Data-from-U-S-Early-Access-Program-Evaluating-MIPLYFFA-arimoclomol-in-Niemann-Pick-Disease-Type-C-NPC.html", "message": "News view counter 862933 successfully enlarged"}